Table 3.
Process measures and clinical outcomes
| Outcomes | Intervention I, n, Odds Ratio (95% Confidence Interval) |
Intervention II, n, Odds Ratio (95% Confidence Interval) | Trend P Value |
|---|---|---|---|
| (n=159) | (n=105) | ||
| Documented AKI | 111 2.80 (1.38 to 5.67) | 77 2.66 (1.21 to 5.81) | 0.006 |
| Clinical action | 2.54 (0.50 to 12.83) | 2.01 (0.35 to 11.73) | 0.37 |
| Repeat Cr | 1.60 (0.77 to 3.30) | 1.69 (0.77 to 3.73) | 0.17 |
| Encourage hydration | 1.57 (0.87 to 2.83) | 1.82 (0.95 to 3.48) | 0.06 |
| Discontinuation of nephrotoxins | 1.60 (0.76 to 3.35) | 4.88 (2.27 to 10.50) | <0.001 |
| Change dosing | 1.02 (0.57 to 1.81) | 0.60 (0.31 to 1.17) | 0.17 |
| Nephrology consult | 0.33 (0.07 to 1.70) | — | 0.05 |
| Hospitalization | 0.95 (0.42 to 2.17) | 1.20 (0.50 to 2.90) | 0.71 |
| Recovery within 7 days | 34 0.60 (0.29 to 1.2) | 18 0.92 (0.37 to 2.30) | 0.61 |
| Prolonged AKI | 33 0.92 (0.54 to 1.58) | 19 0.79 (0.42 to 1.48) | 0.46 |
| Progression to CKD | 49 0.91 (0.43 to 1.94) | 33 1.97 (0.680 to 5.72) | 0.31 |
AKI, acute kidney injury.